Wikisage, the free encyclopedia of the second generation, is digital heritage
Drisapersen: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
(→Links: todo) |
||
| Line 7: | Line 7: | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/ Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/ Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study] | ||
[[Eteplirsen]] | |||
{{refs}} | {{refs}} | ||
Revision as of 23:33, 11 September 2019
An exon skipping experimental Medicine[1] [2] PRO051/GSK2402968 is considered an orphan drug Duchenne muscular distrophy
Links
Duchenne muscular dystrophy: Still an incurable disease
| References: |